Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy? - Wikidata - awgldk - TriplyDB

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

http://www.wikidata.org/entity/Q44613013

about

Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!Changes in the perceived epidemiology of primary hyperaldosteronism Does eplerenone have a future in the management of hypertension in Europe?Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure.Long-term use of aldosterone-receptor antagonists in uncontrolled hypertension: a retrospective analysis.Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension.Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus.Serum potassium levels predict blood pressure response to aldosterone antagonists in resistant hypertension

P2860

Q26776149-C8F21AEF-A6F1-452E-8B05-2578F5A36348 Q35151575-E3FB6280-2516-41DB-890C-3C10D54890CD Q36568473-619D1600-7DF6-4A43-9F42-18534401F070 Q37000764-2110F29D-E1FA-476D-ABA4-D8221E56D19A Q41814119-0D239D07-464E-481A-BC81-33D9CA217EBC Q43253098-D982192F-02BB-44B0-9DC9-76E75773E0B1 Q51481581-71A088B0-BFB5-4CBB-9095-D12E4AA6870A Q58855232-101C9078-CDE3-46DF-8D16-163FAE555985

P2860

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

http://www.wikidata.org/entity/Q44613013

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

@en

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

@nl

type

label

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

@en

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

@nl

prefLabel

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

@en

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

@nl

P1433

Q44613013-8B0F679F-FE8F-4B32-939E-1BABE2753DF5

P1476

Q44613013-13775ED4-2851-4A92-8133-E8D85B975016

P2093

Q44613013-905C80F6-D3B1-4306-8E20-417E82095D1D

Q44613013-9A2EC14A-4AB7-430E-8B0A-9D77FE0295CB

Q44613013-B3EA29AB-0A7B-4AD5-8236-4EEEF4B151D4

Q44613013-BE5EDE8E-C18B-4771-9082-BC6FEB3758A2

Q44613013-CDC4E42E-EEED-4849-8D0E-DD808DF18302

P2860

Q44613013-0B5B6463-BB94-4121-9C8F-4A9321370579

Q44613013-157FA1CC-243A-4E35-B86A-0A937ED3F7B3

Q44613013-1FE4A4EF-FCF3-44B3-8D30-D9558BE43F77

Q44613013-2639F609-2E43-4A65-ADAE-8830DE6C0E33

Q44613013-4C7BDBE6-D04A-4A37-A362-2C912F3CB939

Q44613013-58C29CD3-2E1E-48A7-AEFD-572DE9D218AC

Q44613013-68C888D6-F4D4-4F19-BE7D-7A38CA5AA234

Q44613013-8A881055-0FE6-4FB1-A426-0CB07890E820

Q44613013-8B1A0F46-E49F-437C-A5E9-2648561D6E75

Q44613013-8CF32881-2A21-4296-8E54-F98A0859F0A3

P304

Q44613013-485EC32C-22BF-4054-9783-17FF5BA5735B

P31

Q44613013-F70CCAF1-1B73-4ED3-9EBE-57400CEDF95B

P356

Q44613013-2338D666-2CB3-4955-A61E-78D77DCC22E6

P433

Q44613013-A5E80FD8-DC31-41BF-B035-A5399C39DC6B

P478

Q44613013-43BB80DF-2D0A-41A8-9AD9-F2C3AA5C164F

P50

Q44613013-34AD8A15-195F-4C81-AB27-CE616383D74F

P577

Q44613013-29A2AF96-56C6-43F1-8A40-BB558963F014

P698

Q44613013-D1E01CF8-F0C7-4169-8C83-03ED21D67D91

P356

0091270003258189

P1433

The Journal of Clinical Pharmacology

P1476

Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?

@en

P2093

Barbara Roniker

http://www.w3.org/2001/XMLSchema#string

Kaffa Fakouhi

http://www.w3.org/2001/XMLSchema#string

L Michael Prisant

http://www.w3.org/2001/XMLSchema#string

Scott L Krause

http://www.w3.org/2001/XMLSchema#string

Weizhong He

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin II receptor blockers: review of the binding characteristics.

The promise of selective aldosterone receptor antagonists for the treatment of hypertension and congestive heart failure.

Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.

Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension.

Losartan: first of a new class of angiotensin antagonists for the management of hypertension.

Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises.

Unrelated responses of brachial artery hemodynamics and renin-angiotensin system to acute converting enzyme inhibition by enalaprilat in essential hypertension.

Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients.

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

P304

1203-1210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270003258189

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14551174

http://www.w3.org/2001/XMLSchema#string